- Front Matter
1
- 10.1016/j.amjsurg.2026.116868
The final Year(s): Reflections and revelations on surgical fellowship.
- May 01, 2026
- American journal of surgery
- Sullivan A Ayuso + 1 more +1
Publications from 2021 to 2026
Showing 10 of 201 papers
The final Year(s): Reflections and revelations on surgical fellowship.
957: PATHWAYS TO IMPROVE DELIRIUM SCREENING
Introduction: The purpose of this study was to investigate the trauma community’s use of the CAM scoring for delirium, and what shortfalls they believe it has in practice. Additionally, we wanted to discover what can be done to improve delirium care. Methods: A ten-question mixed-methods survey was sent to the members of the Society of Trauma Nurses via Email listserv. The survey included two open-response questions, allowing three responses for each question, and eight multiple-choice questions about delirium and delirium scoring. Results: There were 130 respondents who completed the survey. The majority (42.5%%) are using CAM-B for scoring delirium, however, it was shocking that we discovered 35% indicated currently not using any scoring for delirium. Sleep/wake cycle bundle was reported as the most utilized intervention with CAM-positive patients. Mandatory screening was the most suggested change for improvement of delirium management. Conclusions: A significant amount (35%) of our participants were not using any screening tool for delirium. Education of providers and nurses of the importance of CAM scoring as well as improving the utilization of the CAM score across all areas of inpatient care was indicated as much needed by participants. Those surveyed did not think that facilities had protocolized interventions when a patient was CAM positive, and also they expressed frustration with using the tool screening patients with traumatic brain injury and dementia. This is a potential practice improvement area to improve patient outcomes. The new unifying definition of delirium is a one of the many ways we are improving care for these patients, however this study indicated that additional research is needed to discover the best ways to educate nurses and providers on the importance of delirium and utilizing EMR communication now that the platform has become more advanced.
Read moreNeedle gauge and patient pain in steroid injection of the knee: a prospective randomized controlled trial
Background: Intra-articular corticosteroid injection (IACI) is a common conservative treatment modality for knee osteoarthritis (OA) but can cause procedural discomfort. Needle gauge is a modifiable factor that may influence patient pain perception, though evidence remains limited. This study compared 18- versus 22-gauge needles in knee IACIs. Methods: The authors performed a single-blinded, prospective, randomized controlled trial at a public teaching hospital (San Joaquin General Hospital, in French Camp, CA) from May 10, 2023 to October 16, 2024. Adults with primary knee OA indicated for corticosteroid injection were randomized to receive injection with either an 18-gauge or 22-gauge needle. All injections were performed via the superolateral approach using triamcinolone acetonide and lidocaine. Pain scores were measured using a visual analogue scale (VAS). Secondary outcomes included anticipated pain, nervousness, and satisfaction. Results: Twenty-six patients were randomized (14 in the 18-gauge group, 12 in the 22-gauge group). Median injection pain was similar between groups (median 2.5 vs 2.5, p=0.71). Post-injection pain was lower in the 18-gauge group (median 1.5 vs 3.5, p=0.21), but not statistically significant. Pre-injection nervousness correlated with both injection pain (ρ=0.50, p=0.011) and post-injection pain (ρ=0.55, p=0.004). Conclusions: Needle gauge did not significantly affect pain or satisfaction during knee IACIs. Psychosocial factors appear to play a greater role in pain perception than needle size.
Read moreInfratentorial superficial siderosis : a diagnostic challenge from the general practice to the hospital
Superficial siderosis is a rare neurological evolutive condition that encompasses two distinct entities classified according to their cortical or infratentorial localisation. The disease is caused by the neuronal destruction of the central nervous system linked with hemosiderin deposits. The aetiology is a sustained low-intensity bleeding located at the supratentorial subarachnoid space for the cortical superficial siderosis or from the subarachnoid space for the infratentorial superficial siderosis. The triad sensorineural hearing loss, cerebellar ataxia and pyramidal signs should suggest infratentorial superficial siderosis. The diagnosis is made using central nervous system MRI. The management relies on the identification and surgical correction of the bleeding source. The benefit of medical treatment is discussed.
Read moreTherapeutic plasma exchange and intravenous immunoglobulin facilitate safe heparin re-exposure in acute heparin-induced thrombocytopenia: A five-patient case series
PART C OF RAINFOL™-01: A PHASE 1/2 STUDY OF SINGLE-AGENT RINATABART SESUTECAN IN PATIENTS WITH ADVANCED AND/OR METASTATIC PLATINUM-RESISTANT OVARIAN CANCER
Treatment of cannabinoid hyperemesis syndrome: A systematic review and treatment algorithm for consultation-liaison psychiatrists.
ID# 1906099 Limb Survival in SCS Patients with Chronic Limb Threatening Ischemia: A US Payer Database Analysis
Comparative Efficacy of Novel Skin Barrier Repair Cream and Urea 40% for the Management of Pedal Fissures.
Pedal fissures present challenges for affected individuals, from cosmetic concerns to potential infection risks. Urea 40% was previously a common treatment for pedal fissures, particularly in its prescription form, but its use has declined and it is now widely available over the counter and is no longer covered by many insurance plans. Alternatives to prescription urea 40% often contain additional ingredients, such as salicylic acid. Although a common exfoliant in dermatologic treatments, salicylic acid can cause burning and exacerbate irritation, particularly when used on pedal fissures, thus hindering healing. This study aimed to assess the efficacy of urea 40% compared with a novel skin barrier repair cream designed to address pedal fissures without the irritation while still providing healing results. The novel skin barrier repair cream uses natural ingredients without fragrances or dyes and incorporates hyaluronic acid, which helps the skin retain moisture and stay hydrated without breaking down the surrounding tissue. This double-blind study enrolled 48 participants who were assessed every 2 weeks over 28 days of treatment. Participants were divided into two groups, each receiving either urea 40% or the novel skin barrier repair cream for daily use. Follow-up visits included detailed records of xerosis and fissure progression, with parameters analyzed for comparative efficacy. Significant improvement in function was observed in the group treated with the novel skin barrier repair cream. The results showed minimal statistical difference in healing between the novel skin barrier repair cream and urea 40% across all measured parameters. The novel skin barrier repair cream provides a comparably effective treatment for pedal fissures without additional side effects. This finding highlights the potential of the novel skin barrier repair cream as a viable alternative to the currently available over-the-counter formulations, addressing both effectiveness and affordability in managing pedal fissures.
Read morePOSTER: ALL-860 Incidence and Characteristics of Venous Thromboembolism in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Systematic Review